Shares in ResMed (NYSE:RMD) are up after the medical device maker posted third-quarter results that beat the consensus on Wall Street. The San Diego-based company reported profits of $105.4 million, or 73¢ per share, on sales of $662.2 million for the three months ended March 31, for a 12% growth in sales and a profit loss of […]
ResMed buys Korean home healthcare supplier HB Healthcare
ResMed (NYSE:RMD) said today that it bought Korean home healthcare equipment supplier HB Healthcare for an undisclosed amount. San Diego-based ResMed said the acquisition is aimed at extending its decade-old footprint in South Korea to “millions more patients through HBH and its wider network of trusted distributor partners.” “ResMed has reaffirmed its leading role in Korea’s […]
At-home digital health: Here’s what you need to know
Demand is increasing for at-home digital health systems, where sensors follow people’s health data and automatically turn them into real-time insights for themselves and their health providers. From ResMed and its connected CPAP technology to Clarify Medical getting user feedback for its light therapy system for skin conditions, medical device companies have started to score […]
Propeller Health study suggests 84% of asthma inhaler use performed incorrectly
ResMed (NYSE:RMD) subsidiary Propeller Health today released results from a new study exploring real-world use of rescue or controller inhalers that indicated that the majority of users did not use their inhalers properly. Results from the research were published in The Journal of Allergy and Clinical Immunology: In Practice, the Madison, Wisc.-based company said. Read the whole story on […]
ResMed, Fisher & Paykel agree to settle all outstanding patent suits
ResMed (NYSE:RMD) and Fisher & Paykel Healthcare (NZE:FPH) said today in a joint announcement that they have reached an agreement to settle all outstanding patent infringement disputes across all global venues. While the terms of the deal remain confidential, both San Diego-based ResMed and Auckland, New Zealand-based Fisher & Paykel said it involved no payments from either party. […]
Propeller, Orion to develop digital asthma, COPD therapy
Propeller Health said today that it inked a deal to connect Orion’s Easyhaler line of inhalers for asthma and COPD with Propeller’s digital medicine platform. The two companies plan to co-develop a sensor that will attach to Orion’s inhalers and pair with a mobile app. Get the full story at our sister site, Drug Delivery Business […]
ResMed shares plunge on Q2 sales miss
Shares in ResMed (NYSE:RMD) fell nearly 20% after the respiratory-focused medical device maker missed sales expectations on Wall Street with its second quarter earnings results. The San Diego-based company posted profits of $124.6 million, or 86¢ per share, on sales of $651.1 million for the three months ended December 31, for massive bottom-line growth of approximately […]
ResMed closes $225m Propeller Health purchase
ResMed (NYSE:RMD) said yesterday that it completed its $225 million acquisition of Propeller Health and its digital medicine platform. Lead by CEO David Van Sickle, Propeller will continue to operate as a standalone business within ResMed’s respiratory care portfolio, the companies reported. Get the full story at our sister site, Drug Delivery Business News.
ResMed’s Brightree picks up Apacheta
ResMed (NYSE:RMD) subsidiary Brightree said this week that it paid an undisclosed amount to bolster its software-as-a-service holdings with Apacheta. Media, Pa.-based Apacheta makes mobile apps that allow companies to automate and streamline business processes in sales, marketing, logistics and field services. “Apacheta solves many of the business challenges [home medical equipment companies] face in managing deliveries, particularly […]
ResMed puts $225m on the table for Propeller Health
ResMed (NYSE:RMD) said today that it inked a deal to acquire Propeller Health and its digital medicine platform for $225 million in cash. Propeller Health, which sells small sensors that attach to inhalers and track medication use, will operate as a standalone business under ResMed’s respiratory care portfolio. Get the full story at our sister site, Drug Delivery […]
ResMed closes $750m MatrixCare buy
ResMed (NYSE:RMD) said today that it closed the $750 million acquisition of MatrixCare and its post-acute-care software. The San Diego-based respiratory care giant said it funded the buyout, which represents a 25x EBITDA multiple, using its credit facility. Bloomington, Minn.-based MatrixCare put up sales of $122 million last year, ResMed said. “We’re all excited to have quickly closed this important […]
- 1
- 2
- 3
- …
- 10
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube